Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT06959654 Sponsor: Sohag University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT06959654
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 and over (both male and female) who have been diagnosed with ulcerative colitis based on laboratory, clinical, and internal examination (endoscopy) results.
  • The trial is looking to include 40 healthy volunteers (with no ulcerative colitis) and 50 people newly diagnosed with confirmed ulcerative colitis, covering both those with currently active symptoms and those without active symptoms.
  • Ulcerative colitis activity is measured using a scoring tool called the Simple Clinical Colitis Activity Index (SCCAI), which asks about bowel habits during the day and night, urgency to use the bathroom, blood in the stool, general wellbeing, and symptoms affecting other parts of the body — a score of 5 or higher out of 20 indicates active disease.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another condition causing widespread inflammation in the body at the same time, such as rheumatoid arthritis or asthma.
  • People with a history of cancer.
  • People who have been found to have an autoimmune disease, microscopic colitis, or Crohn's disease.
  • People with ulcerative colitis who are already receiving treatment for it.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01110071828

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 May 2025
Est. completion
1 May 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Assessment of Serum value of oncosatin M and galactin 3 patients with ulcerative colitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov